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Abstract: 
Objective: Purpose is to review the annotation of C1236T mono-nucleotide polymorphism of ABCB1 gene along with 
non-receptiveness towards antiemetic handling in victims before surgery. 
 Methods: Respective medical test was held at Sir Ganga Ram Hospital in Lahore during 2017-18, consisted of victims 
suffering laparoscopic cholecystectomy. All the victims were provided with dosage of 0.1 mg/kg ondansetron 
intravenously about half an hour prior to the termination of operation and illustrations for Deoxyribonucleic acid 
were performed. The regularities of genetic material for mono nucleotide polymorphism were evaluated through the 
use of PCR along with RFLP. 
Results: Among a total of 426 victims, 201(47%) showed resistance against nausea or vomiting, while 225(52.8%) 
were affected by the disease. Evidence of nausea and vomiting after 2 hours from surgery  were rare in victims having 
relation with 1236TT as compared to 1236(probability <0.001). Victims of CC inheritance showed huge evidence as 
compared to others i.e. p < 0.001. 
Conclusion: To expect reaction towards ondansetron Polymorphism of ABCB1 gene plays an important role. 
Keywords: ATP-binding cassette subfamily B member 1 (ABCB1), Single nucleotide polymorphism, Genotyping, 
Ondansetron, P-glycoprotein. 
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INTRODUCTION: 
A serious issue of nausea and vomiting after surgery 
was reported during antiemetic treatment [1]. It 
donates the pain from which victims are suffering. An 
oppositional serotonin receptor towards ondansetron is 
frequently utilized medicine against nausea and 
vomiting (PONV) which is very useful and secure [2]. 
Despite of its utilization some cases of about 35% 
victims reported PONV which showed that it is not 
effective for all individuals. The motive behind this 
deviation is still mysterious. Several aspects 
contributed to this nausea and vomiting, however, the 
fact of inherited circumstances is considered as the key 
aspect [3]. Ondansetron is documented through 
adenosine 5’-triphosphate-binding cassette belonging 
to subfamily B participant 1(ABCB1) that carries drug 
towards blood brain barricade that governs the 
proportion of drug in central nervous system (CNS). 
 
ABCB1 is the genotype that shows huge 
polymorphism due to which appearance and purpose 
of P-glycoprotein (P-gp) is altered that stimulates the 
drug temperament in the central nervous system 
altering usefulness and dealing results. Huge research 
has been conducted in nucleotide locations G2677T at 
exon 21 and C3435T at exon 27, despite of which 
C1236T got less consideration at exon 24 [4]. 
Moreover, connotational polymorphism in the 
ABCB1 gene and clinical comebacks were inspected 
at various ethnic groups [5-8] but the records for our 
population were lacking. Evaluation of the incidence 
of  structurally significant mono-nucleotide 
polymorphism for the inhabitants is of huge concern 
as it is really difficult for someone to decode the 
research of pharmacogenetic research in a population 
to other. The research conducted by various clinical 
staff were not as accurate for huge emetogenic 
operations after surgery. These type of research 
surveys on pharmacogenetics of anesthesia are scarce. 
Further expertise is required to decode the outcomes 
of pharmacogenetic surveys into anesthesia. A 
strategy was built to evaluate the outcome of C1236T 
polymorphism with respect to cancer victims on 
therapy results of prophylactic ondansetron in victims 
after surgery suffering laparoscopic cholecystectomy 
having primary anesthesia. 
 
It was assumed that ABCB1 polymorphism plays a 
vital role in the evaluation of reaction of victims after 
surgery towards ondansetron and polymorphism in 
gene transfer contribute a lot in interindividual 
deviation. 
 
PATIENTS AND METHODS: 
During 2017-18, a respective clinical survey was held 
which consists of victims suffering through elective 
laparoscopic cholecystectomy. When permission was 
granted from Ethical Committee of Centre for 
Research in Experimental and Applied Medicine 
(CREAM), Clinical record was gathered, and 
sampling was performed at Sir Ganga Ram Hospital, 
Lahore. Inscribed conversant agreement was derived 
from all the subjects of older age despite of the 
categorization of male and female casually chosen 
from non-probability successive sampling relating to 
various areas of Pakistan in order to get participation 
from all regions. Victims of 18-65 years belonging to 
American Society of Anesthesiologists(ASA) bodily 
state of I or II planned to suffer elective laparoscopic 
cholecystectomy were elected. Victims with some 
previous records of hypersensitivity to 5-HT3 receptor 
against it, hepatic or any renal disease or those which 
utilized antiemetics in 24 hours prior to survey were 
not included. Complete evaluation of every subject 
having exhaustive medical record was performed 
comprising of the record of smoking, motion sickness 
and any previous record of PONV. 
 
Vitals of victims, consisting of electrocardiography, 
non-invasive blood pressure (BP) and pulse oximetry, 
were observed regularly if the victim got into the 
surgery room. Training was held with 4-5 mg/kg 
thiopental, and endotracheal intubation was performed 
with 0.6 mg/kg rocuronium. Also, 1.5-2.0 vol% 
sevoflurane and nalbuphine 0.1 mgkg-1 was utilized 
for regulation of anesthesia. Through the technique a 
bispectral index score (BIS) observer was utilized 
regularly and deepness of anesthesia was regulated 
among 50-60. All the victims were treated with 
4mg(0.1 mg/kg) ondansetron through veins (IV) half 
an hour prior to operative completion. Overall dosage 
of nalbuphine utilization during anesthesia was 
recorded. After entrance of post anesthesia care unit, 
the suffering data was noted. In duration after surgery, 
all victims were monitored for indications of nausea 
and vomiting. PONV during initial 2 hours and at 2-
24 hours was observed. Victims showing any 
symptoms of nausea and vomiting were assigned to 
the category of non-responders. These victims were 
regarded as treatment abortive and were treated with 
salvage antiemetic. Victims were assigned to the 
responder’s category on the basis of no clear 
symptoms of nausea and vomiting after surgery. The 
blood samples of 5ml were obtained from each victim. 
 
Average biological procedures of deoxyribonucleic 
acid (DNA) withdrawal were utilized to separate the 
genomic DNA from entire blood.[10] PCR-RFLP was 
utilized for genotyping of C1236T. DNA 
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augmentation was performed through utilization of 
sense:5’GCCACaGTCTGCCCACTC3’ and anti-
sense: 5’CCCATaTCGAAAAGAAATTAAG3 
primers for the area sheltering the C1236T SNP. The 
procedure of PCR was performed in the total 
concentration of 20µl having 10X PCR buffer lacking 
MG2+, 25 Mm MGCL2, 2 mMdNTPs, 5U Taq 
polymerase, 10 𝜇M forward and reverse primers and 
40 mg DNA of genomic origin. Products of 
Polymerase Chain Reaction were imperiled to 
assimilation through the aid of restriction enzyme 
(Hae III). After assimilation the homozygous 
population for primary allele have 3 fragments of 
272bp, 63bp and 35bp. This heterozygous population 
is composed of primary and secondary allele leading 
to 4 fragments of 272bp, 98bp, 63bp and 35bp. The 
secondary allele of homozygous population develope 
2 fragments of 272bp and 98bp fragments. Evaluation 
of the record was performed through utilization of 
SPSS 22. For regulation of the Single Nucleotide 
Polymorphism variation from Hardy Weinberg 
equilibrium through Fisher’s exact test was performed. 
Regulation variations in genotype and occurrence of 
PONV were associated with chi-square test. 
Utilization of odds ratios (ORs) and 95% confidence 
interval for correlation of ABCB1 genotypic 
deviations with the existence of PONV. P<0.05 was 
regarded as substantial. 
 
RESULTS: 
Out of 426 victims, 70(16.4%) showed CC genotype, 
188(44%) with CT while 168(39.5%) with TT(Table 
1). Substantial variation was lacking in features and 
clinical explanation depending on the genotypes 
(p>0.05). From C1236T variants, occurrence of 
PONV within 2 hours to operation was substantially 
less in victims having 1236TT genotype as compared 
to 1236 genotypes (TT vs CC+CT; p<0.001). 
Existence of PONV was substantially huge in victims 
having CC genotype within 2 hours as compared to 
1236 genotype (CC vs CT+TT; p<0.001)(Table 2). 
Reaction towards ondansetron depending on PONV 
showed no variation among genotypes during 2-24 
hours after operation. Reaction of victims suffering 
from nausea and vomiting was minimized showing a 
rate of 62(14.5%) victims.  
 
Table-1: Patient characteristics and clinical details according to C1236T genotype. 
Variables  
CC (n=70) 
Genotype 
CT (n= 188) 
TT (n=168) 
Sex: M/F 27/43 98/90 64/104 
Age (years) 42.84±10.43 41.98±8.65 42.82±8.29 
History of Smoking 7 30 19 
History of PONV 8 15 14 
History of motion sickness 5 22 11 
Duration of Surgery 76.93±11.12 77.23±12.06 76.76±9.96 
Nalbuphine doses in operating room (mg/kg) 6.66±0.78 7.10±0.31 6.23±0.42 
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Table-2: The effects of C1236T ABCB1 polymorphism on the antiemetic efficacy of ondansetron at 2 hours 
and at 2-24 hours. 
Genotypes First 2 hours 2-24 hours 
Responders Non-Responders Responders Non-Responders 
CC 23(32.9%) 47(67.1%) 59(84.3%) 11 (15.7%) 
CT 74(39.4%) 114 (60.6%) 156(83%) 32 (17%) 
TT 104 (61.9%) 
OR (95% CI), p-values 
64 (38.1%) 149(88.7%) 19 (11.3%) 
CC+CT vs TT 2.6972(1.08-4.02) < 0.001∗ 1.5684(0.87-2.79) 0.125 
CC vs CT + TT 0.4894(0.28-0.84) <0.001∗ 1.3344(0.65-2.72)0.763 
CI indicates confidence interval; OR, odds ratio; *p<0.05 
ABCB1:Adenosine 5’-triphosphate binding cassette subfamily B member 1. 
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DISCUSSION: 
Exchange of P-gp is determined by a huge 
polymorphic gene ABCB1. Single Nucleotide 
Polymorphism has little research done in case of 
healthy individuals, moreover, clinical position is the 
variation at location 1236 in exon 12(C1236T). This 
type of polymorphism alters the appearance and 
working of P-gp influencing the accuracy of medicine 
acting as substrates of P-gp. [10, 11] It is very obvious 
that polymorphism of ABCB1 evaluation could be 
performed in person through therapeutic strategy. The 
results are un-satisfying and opposing the hushed 
C1236T polymorphism among deviated individual 
samples. A few surveys maintained the impact of 
genetic deviation on the accuracy of antiemetics [12-
14] A few surveys build a linkage for C1236T 
polymorphism and clinical results. [5,12,15-17] 
despite of others which are unable to perform this 
[7,18].  
 
Variation in outcomes between surveys contributed a 
lot towards phenotypic explanation, tiny sample and 
connectivity in substrate particularly among P-gp and 
various medicine efflux exchangers.[19] It was 
observed that reaction to ondansetron for PONV may 
vary substantially depending on genotypes at 2 hours 
after operation. It was noted that TT genotype at 1236 
was linked with effective medicine reaction at 2 hours 
after the surgery. Chances are there that the victims  
having 1236TT genotype show greater handiness 
towards ondansetron in Central Nervous System hence 
showing good results towards ondansetron, leading to 
lowered action of ABCB1 exchanger. It was also 
monitored that victims having GG genotype showed 
greater symptoms of PONV, leading to the point that 
it will probably act as interpreter of low retort towards 
the substrate of P-gp. So, it is evident to predict that 
genetic deviation of the exchanger can effect the 
accuracy of ondansetron. It was observed that the 
reaction of ondansetron towards PONV would not be 
altered substantially depending on genotypes at 2-24 
hours after operation. 
 
PONV is regarded as a complex issue. Various trouble 
causing aspects were presented among which very less 
showed clarity. Gender, victim’s record regarding 
PONV or motion illness, non-smoking record, volatile 
anesthesia, nitrous oxide, and opioids revealed self-
regulating analysts for PONV among different 
areas.[20] The complex genesis of PONV now-a-days 
is considered a serious reason of predicted treatment 
disappointment. PONV is influenced by a lot of 
aspects. None of the substantial variation was noted 
among risky aspects in relation to the genotypes. 
Various other aspects influencing PONV includes 
anesthetic agent and form of operation that was 
measured in this survey to lower the rate of alteration 
of the outcomes. 
 
In Pakistan it was observed that the individual’s 
reaction to ondansetron regarding PONV was 
substantially affected by ABCB1 gene and C1236T 
polymorphism. Sensitivity towards ondansetron act as 
a clinical analyst for ABCB1 genotypes in different 
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areas around World. For population treatment, 
genotyping of ABCB1 gene polymorphism 
(C12367T), comprising of TT, CT,CC genes play a 
vital role with main focus on genetic structure and 
antiemetic treatment through advancement of 
detection of the non-responders. 
 
In Pakistan, individuals after surgery were monitored 
in this survey by assessing the effects of ABCB1 
genetic modifications towards antiemetic 
effectiveness. The polymorphism of this type was not 
observed on a large scale before. This also build the 
idea of application of effective utilization of 
ondansetron by showing a function of ABCB1 
polymorphism C1236T for therapeutically applied 
results. Moreover, for application of genetic 
examination regularly for clinical expertise, more 
endorsement is needed. It is recommended to perform 
analysis on function of polymorphisms including 
proteins which donate their fragment in exchange of 
medicine for solution of medical avoidance. 
 
CONCLUSION: 
Among a total of 426 victims, 201(47%) showed 
resistance against nausea or vomiting, while 
225(52.8%) were affected by the disease. Evidence of 
nausea and vomiting after 2 hours from surgery  were 
rare in victims having relation with 1236TT as 
compared to 1236(probability <0.001). Victims of CC 
inheritance showed huge evidence as compared to 
others i.e. p < 0.001. ABCB1 gene polymorphism act 
as a better predictor to forecast the reaction for 
ondansetron, while genetics provide basis for 
maintenance of PONV regarding P-gp substrates. 
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